Status:

RECRUITING

The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults

Lead Sponsor:

TC Erciyes University

Conditions:

Pain

Ecchymosis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Subcutaneous (SC) injection applications are the process of administering the drug to the loose connective tissue under the skin and is one of the most frequently applied parenteral drug administratio...

Detailed Description

Subcutaneous (SC) injection applications are the process of administering the drug to the loose connective tissue under the skin and is one of the most frequently applied parenteral drug administratio...

Eligibility Criteria

Inclusion

  • Able to speak and understand Turkish,
  • Those between the ages of 18-65,
  • Oriented to place and time,
  • Having no vision or hearing problems,
  • Not using psychiatric medication due to any psychiatric disease,
  • Not using central nervous system medication,
  • Not using narcotic analgesics,
  • Having a Visual Comparison Scale pain score of zero at the time of application,
  • Those who have not had SC injection in the last month,
  • Low molecular weight heparin therapy is ordered (Enoxaparin Sodium 1\*4000 IU),
  • Having an average pressure pain threshold of 8-16 pounds (Lb) with the Baseline Algometer device,
  • Has normal platelet, INR, and aPTT values,
  • Individuals who volunteer to participate in the study and sign the written voluntary consent form will be included in the research.

Exclusion

  • Vital signs not within the reference range,
  • Those with signs of phlebitis, scar tissue, dermatitis, incision and infection in the area where the intervention will be performed,
  • Having had a mastectomy,
  • Patients who declare that they are addicted to alcohol and drugs will not be included in the research.

Key Trial Info

Start Date :

March 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06222216

Start Date

March 1 2024

End Date

October 1 2024

Last Update

May 13 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Erciyes University Medical faculty hospital

Kayseri, Talas, Turkey (Türkiye), 38280